Biolevate
Biolevate Raises €30M Series A for Life Sciences Automation
Biolevate announced €30M in Series A financing on September 22, 2026. Biolevate raised a €30 million Series A co-led by RAISE France and Orange Ventures to expand evidence-grade automation for regulated life sciences operations.
Round details
The financing includes backing from RAISE France, Orange Ventures, MSD Global Health Innovation Fund, EQT Ventures. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: €30M
- Headquarters: Paris, France
How the company plans to use the capital
Biolevate said the capital will support international expansion, deeper product capabilities, larger enterprise deployments, and a new Boston office serving the U.S. life sciences market.
Why this matters for GTM teams
The round shows growing demand for AI systems that automate regulated scientific and operational work while preserving evidence, traceability, and domain context.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Biolevate Series A announcement.
Company Info
Investors (4)
Share
Related Reports
Basecamp Research Raises $140M Series C for AI-Designed Medicines
Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.
Ema Raises $77M Series B to Expand Its Enterprise AI Employee Platform
Ema raised a $77 million Series B led by Creaegis, bringing total funding to $140 million as it scales AI agents across enterprise workflows.
Chamelio Raises $26M Series A for AI-Native Legal Operations
Chamelio raised a $26 million Series A led by Entrée Capital to replace legacy contract-management systems with agentic legal operations.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free